EXEL vs XPEV · P/E 17, rev $628.7M vs rev $895.7M
Exelixis Inc (EXEL) versus Xpeng Inc (XPEV) — a side-by-side from cached financials, not a winner call.
Exelixis Inc (EXEL) is a biotechnology company listed on US.
Xpeng Inc (XPEV) is a auto manufacturers company listed on US. It is led by Xiaopeng He.
Latest reported EXEL revenue for 2026-07-03 was $628.7M. Net income was $212.1M. Revenue was up 2.9% from 2026-04-03 to 2026-07-03. EXEL currently screens at market cap $12.69B and trailing P/E 16.7.
Latest reported XPEV revenue for 2020-12-31 was $895.7M. Net income was -$418.7M. XPEV currently screens at market cap $20.28B.
EXEL currently screens at market cap $12.69B and trailing P/E 16.7. XPEV currently screens at market cap $20.28B.
Not investment advice. Open the EXEL and XPEV stock pages for the full models.
Not investment advice.